MET-Mediated Drug Resistance in Colorectal Cancer: In Silico Analysis of the Potential of Epicatechin-3-Gallate and Epigallocatechin-3-Gallate as Therapeutic Adjuvants. IHRJ. 2026;3((1-Supp):05-16. doi:10.47963/ihrj.v3i(1-Supp).2075